Skip to content

MyHand: An Active Hand Orthosis for Stroke Patients

MyHand: An Active Hand Orthosis for Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03767894
Enrollment
12
Registered
2018-12-07
Start date
2017-11-13
Completion date
2019-06-27
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Hand orthosis, Stroke

Brief summary

This study seeks to explore the efficacy of several control mechanisms for the device and the impact of a device training program on its utility as a neuroprosthetic and training tool for upper limb recovery.

Detailed description

Hand rehabilitation through occupational therapy is critical for many stroke survivors, but it is also greatly limited by insurance coverage, shortage of therapists, and logistic constraints. To address this, stroke patients need a rehabilitation method they can use on their own, without direct clinical supervision, and for activities of daily living. MyHand is a wearable and active hand orthosis consisting of a glove and forearm splint, equipped with actuators and tendons which connect to the fingers.

Interventions

DEVICEEMG Band

The MyHand orthosis provides tension to the digits to open the fingers on demand. This group will wear an EMG band to control and activate the MyHand orthosis.

DEVICEShoulder harness

The MyHand orthosis provides tension to the digits to open the fingers on demand. This group will wear a shoulder strap to control and activate the MyHand orthosis, either with shoulder elevation or shoulder depression.

Sponsors

Wallace H. Coulter Foundation
CollaboratorOTHER
U.S. National Science Foundation
CollaboratorFED
Columbia University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Subjects are assessed by an independent therapist. The therapist is not blinded to the control mechanism used during treatment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects over 18 years of age * History of stroke resulting in significant upper limb impairment * Full passive range of motion * Gross control of the proximal upper extremity * Lacks timely grasp/release * No more than moderate flexor tone * Intact cognition

Exclusion criteria

include: * Other Neurological/orthopedic disorders * Excessive spasticity/contracture

Design outcomes

Primary

MeasureTime frameDescription
Score on Action Research Arm Test (ARAT)Baseline; Post-test at Week 4The ARAT is a 19-item measure that assesses upper limb functioning. The ARAT is divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from 0 (cannot perform) to 3 (normal performance). Scores on the ARAT range from 0-57 points, with higher scores indicating better performance.
Score on the Upper Extremity Component of the Fugl-Meyer Scale (UEFM)Baseline; Post-test at Week 4The Fugl-Meyer (FM) Assessment of Motor Recovery evaluates and measures recovery in post-stroke hemiplegic patients. The FM uses a 3-point ordinal scale from 0 (cannot perform) to 2 (performs fully). The FM has 5 domains with a maximum score of 226 points. Subscales can be administered with out using the full FM. The Upper Extremity component (UEFM) consists of 33 items with a score range of 0-66. Higher score indicate better performance. Please note: An a prior decision was made to only perform the UEFM once at post-testing: post test without robotic assistance. The UEFM assesses capacity of the arm primarily through gross motor tasks, and comparatively few grasping and pinching tasks. Thus, it was presumed that robotic assistance would have minimal influence on UEFM scores. In other words, the UEFM was intended as a outcome measure to primarily evaluate the rehabilitative effects of training with the device, as opposed to evaluating the assistive capacity of using the device.

Secondary

MeasureTime frameDescription
Score on Modified Ashworth Scale (MAS)BaselineThe Ashworth or Modified Ashworth Scale (MAS) is a measure of spasticity originally developed as a simple clinical classification to assess the anti-spastic effects of carisoprodol in multiple sclerosis. It is rated on a 5-point nominal scale using subjective clinical assessments of tone ranging from 0 (no increases in tone) to 4 (limb rigid in flexion/extension or abduction/adduction). Please note: MAS is officially scored on a 5-point scale that includes 1+ (full range: 0, 1, 1+, 2, 3, 4). However non-numeric scores are not allowable in the Outcome Measure Data Table. Therefore, the scores were transformed from a 0-4 scale (including 1+) to a 0-5 scale (excluding 1+). The reported medians for all but Finger Flexors were not impacted by the scale transformation. Finger Flexor median is reported as 2 in the Outcome Measure Data Table, but this can be understood as a true median of 1+ if using the original MAS scoring scale.
Score on Box and Blocks Test (BBT)Baseline; Post-test at Week 4The BBT measures unilateral gross manual dexterity using blocks and a 2-compartment box. At the start, there are 150 blocks in one compartment and the score represents the number of blocks transferred from one compartment to the other compartment in 60 seconds. Each hand is scored separately, however only scores for the impaired (hemiplegic) hand are reported. Scores can range from 0-150, with higher scores indicating better performance of manual dexterity.
Number of Participants Completing Treatment Protocol4 WeeksThe number of participants who completed the full treatment protocol (12 training sessions).
Total Number of Adverse Events During Intervention4 WeeksAll adverse events will be tracked during the course of the intervention. The Principal Investigator will review any event and assess it as either adverse or non-significant.

Countries

United States

Participant flow

Participants by arm

ArmCount
MyHand Orthosis
Subjects are trained to control and use the MyHand orthosis either with a shoulder harness or an EMG band. The MyHand orthosis aims to aid in fine motor skills such as picking up and holding items of varying shape, size and weight. EMG Band: The MyHand orthosis provides tension to the digits to open the fingers on demand. This group will wear an EMG band to control and activate the MyHand orthosis. Shoulder harness: The MyHand orthosis provides tension to the digits to open the fingers on demand. This group will wear a shoulder strap to control and activate the MyHand orthosis, either with shoulder elevation or shoulder depression.
11
Total11

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicMyHand Orthosis
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Age, Continuous52 years
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
11 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
6 Participants
Type of Stroke
Hemorragic Stroke
1 Participants
Type of Stroke
Ischemic Stroke
9 Participants
Type of Stroke
Unknown Type (by participant)
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 11
other
Total, other adverse events
0 / 11
serious
Total, serious adverse events
0 / 11

Outcome results

Primary

Score on Action Research Arm Test (ARAT)

The ARAT is a 19-item measure that assesses upper limb functioning. The ARAT is divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from 0 (cannot perform) to 3 (normal performance). Scores on the ARAT range from 0-57 points, with higher scores indicating better performance.

Time frame: Baseline; Post-test at Week 4

Population: Only the 11 subjects that completed the study were included in this analysis.

ArmMeasureGroupValue (MEAN)Dispersion
MyHand OrthosisScore on Action Research Arm Test (ARAT)Baseline13.46 score on a scaleStandard Error 2.184
MyHand OrthosisScore on Action Research Arm Test (ARAT)Post Unassisted (week 4)14.82 score on a scaleStandard Error 2.148
MyHand OrthosisScore on Action Research Arm Test (ARAT)Post Assisted (week 4)13.09 score on a scaleStandard Error 1.43
Comparison: Baseline scores compared to Post Unassisted condition (ARAT performed unassisted/without the use of the MyHand device).p-value: 0.24t-test, 2 sided
Comparison: Post Unassisted condition (ARAT performed unassisted/without the use of the MyHand device) compared to Post Assisted condition (ARAT performed assisted with the use of the MyHand device).p-value: 0.207t-test, 2 sided
Primary

Score on the Upper Extremity Component of the Fugl-Meyer Scale (UEFM)

The Fugl-Meyer (FM) Assessment of Motor Recovery evaluates and measures recovery in post-stroke hemiplegic patients. The FM uses a 3-point ordinal scale from 0 (cannot perform) to 2 (performs fully). The FM has 5 domains with a maximum score of 226 points. Subscales can be administered with out using the full FM. The Upper Extremity component (UEFM) consists of 33 items with a score range of 0-66. Higher score indicate better performance. Please note: An a prior decision was made to only perform the UEFM once at post-testing: post test without robotic assistance. The UEFM assesses capacity of the arm primarily through gross motor tasks, and comparatively few grasping and pinching tasks. Thus, it was presumed that robotic assistance would have minimal influence on UEFM scores. In other words, the UEFM was intended as a outcome measure to primarily evaluate the rehabilitative effects of training with the device, as opposed to evaluating the assistive capacity of using the device.

Time frame: Baseline; Post-test at Week 4

Population: Only the 11 subjects that completed the study were included in this analysis.

ArmMeasureGroupValue (MEAN)Dispersion
MyHand OrthosisScore on the Upper Extremity Component of the Fugl-Meyer Scale (UEFM)Baseline25.36 score on a scaleStandard Error 1.521
MyHand OrthosisScore on the Upper Extremity Component of the Fugl-Meyer Scale (UEFM)Post Unassisted (week 4)28 score on a scaleStandard Error 1.854
Comparison: Baseline scores compared to Post Unassisted condition (UEMF performed unassisted/without the use of the MyHand device).p-value: 0.026Paired sample T-test
Secondary

Number of Participants Completing Treatment Protocol

The number of participants who completed the full treatment protocol (12 training sessions).

Time frame: 4 Weeks

Population: Number of participants who completed the treatment protocol (12 sessions). Only the 11 subjects that completed the study were included in this analysis.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MyHand OrthosisNumber of Participants Completing Treatment Protocol11 Participants
Secondary

Score on Box and Blocks Test (BBT)

The BBT measures unilateral gross manual dexterity using blocks and a 2-compartment box. At the start, there are 150 blocks in one compartment and the score represents the number of blocks transferred from one compartment to the other compartment in 60 seconds. Each hand is scored separately, however only scores for the impaired (hemiplegic) hand are reported. Scores can range from 0-150, with higher scores indicating better performance of manual dexterity.

Time frame: Baseline; Post-test at Week 4

Population: Only the 11 subjects that completed the study were included in this analysis.

ArmMeasureGroupValue (MEAN)Dispersion
MyHand OrthosisScore on Box and Blocks Test (BBT)Baseline47 BlocksStandard Error 2.289
MyHand OrthosisScore on Box and Blocks Test (BBT)Post Unassisted (week 4)35 BlocksStandard Error 1.843
MyHand OrthosisScore on Box and Blocks Test (BBT)Post Assisted (week 4)24 BlocksStandard Error 0.585
Comparison: Baseline scores compared to Post Unassisted condition (BBT performed unassisted/without the use of the MyHand device) of the impaired (hemiparetic) hand.p-value: 0.442Wilcoxon (Mann-Whitney)
Comparison: Post Unassisted condition (BBT performed unassisted/without the use of the MyHand device) compared to Post Assisted condition (BBT performed assisted with the use of the MyHand device).p-value: 1Wilcoxon (Mann-Whitney)
Secondary

Score on Modified Ashworth Scale (MAS)

The Ashworth or Modified Ashworth Scale (MAS) is a measure of spasticity originally developed as a simple clinical classification to assess the anti-spastic effects of carisoprodol in multiple sclerosis. It is rated on a 5-point nominal scale using subjective clinical assessments of tone ranging from 0 (no increases in tone) to 4 (limb rigid in flexion/extension or abduction/adduction). Please note: MAS is officially scored on a 5-point scale that includes 1+ (full range: 0, 1, 1+, 2, 3, 4). However non-numeric scores are not allowable in the Outcome Measure Data Table. Therefore, the scores were transformed from a 0-4 scale (including 1+) to a 0-5 scale (excluding 1+). The reported medians for all but Finger Flexors were not impacted by the scale transformation. Finger Flexor median is reported as 2 in the Outcome Measure Data Table, but this can be understood as a true median of 1+ if using the original MAS scoring scale.

Time frame: Baseline

Population: Baseline scores on MAS. Only the 11 subjects that completed the study were included in this analysis.

ArmMeasureGroupValue (MEDIAN)
MyHand OrthosisScore on Modified Ashworth Scale (MAS)Elbow Flexors (baseline)1 score on a scale
MyHand OrthosisScore on Modified Ashworth Scale (MAS)Elbow Extensors (baseline)1 score on a scale
MyHand OrthosisScore on Modified Ashworth Scale (MAS)Wrist Flexors (baseline)1 score on a scale
MyHand OrthosisScore on Modified Ashworth Scale (MAS)Wrist Extensors (baseline)0 score on a scale
MyHand OrthosisScore on Modified Ashworth Scale (MAS)Finger Flexors (baseline)2 score on a scale
MyHand OrthosisScore on Modified Ashworth Scale (MAS)Finger Extensors (baseline)0 score on a scale
Secondary

Total Number of Adverse Events During Intervention

All adverse events will be tracked during the course of the intervention. The Principal Investigator will review any event and assess it as either adverse or non-significant.

Time frame: 4 Weeks

Population: Number of participants who experienced adverse events. Only the 11 subjects that completed the study were included in this analysis.

ArmMeasureValue (NUMBER)
MyHand OrthosisTotal Number of Adverse Events During Intervention0 adverse events

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026